Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
This project aims to genetically engineer moss to make the molecule strictosidine. Strictosidine is a building block molecule upon which many important medicines are made, including cancer drugs, sedatives, and heart medications; together, these compounds are classified as monoterpene indole alkaloids (MIA). Current methods of making MIAs rely on extraction from plants such as Madagascar periwinkle, which make MIAs in very low amounts and can only grow in tropical locations. This has led to shortages of essential MIA medicines. The moss species Physcomitrium patens can be genetically engineered to make complex plant molecules and grown in enclosed bioreactors anywhere in the world. By making strictosidine in moss, we will be taking the first step in ensuring a secure supply of MIA-based medicines.
Sherryl Bisgrove
BryoSphere
Life Sciences
Manufacturing
Simon Fraser University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.
Mitacs is funded by the Government of Canada, the Government of Alberta, the Government of British Columbia, Research Manitoba, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, Innovation PEI, the Government of Quebec, the Government of Saskatchewan, and the Government of Yukon.